A single amino acid substitution abolishes the heterogeneity of chimeric mouse/human (IgG4) antibody
- 1 January 1993
- journal article
- research article
- Published by Elsevier in Molecular Immunology
- Vol. 30 (1) , 105-108
- https://doi.org/10.1016/0161-5890(93)90432-b
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- The binding affinity of human IgG for its high affinity Fc receptor is determined by multiple amino acids in the CH2 domain and is modulated by the hinge region.The Journal of Experimental Medicine, 1991
- Expression of antibody genes in nonlymphoid mammalian cellsMethods, 1991
- Human IgG subclass pattern of inducing complement‐mediated cytolysis depends on antigen concentration and to a lesser extent on epitope patchiness, antibody affinity and complement concentrationEuropean Journal of Immunology, 1991
- Chimeric B72.3 mouse/human (IgG1) antibody directs the lysis of tumor cells by lymphokine-activated killer cellsCancer Immunology, Immunotherapy, 1990
- Site-specific attachment to recombinant antibodies via introduced surface cysteine residuesProtein Engineering, Design and Selection, 1990
- Human monoclonal IgG isotypes differ in complement activating function at the level of C4 as well as C1q.The Journal of Experimental Medicine, 1988
- Comparison of the effector functions of human immunoglobulins using a matched set of chimeric antibodies.The Journal of Experimental Medicine, 1987
- Nucleotide Sequence of a Human Immunoglobulin Cγ4 GeneDNA, 1981
- Disulphide Bridges of a Human Immunoglobulin G ProteinNature, 1967
- Disulphide Bridges of Immunoglobin G1 Heavy ChainsNature, 1967